SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000799698-16-000027
Filing Date
2016-02-09
Accepted
2016-02-09 17:20:43
Documents
7
Period of Report
2016-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K COVERING LOAN AGREEMENT BETWEEN CYTRX AND HERCULES form8-k.htm 8-K 28000
2 LOAN AND SECURITY AGREEMENT, DATED FEBRUARY 5, 2016, AMONG CYTRX CORPORATION, HE ex10-1_herculeslsa.htm EX-10.1 436736
3 WARRANT AGREEMENT, DATED FEBRUARY 5, 2016, ISSUED BY CYTRX CORPORATION TO HERCUL ex10-2_htcgwarrant.htm EX-10.2 125346
4 WARRANT AGREEMENT, DATED FEBRUARY 5, 2016, ISSUED BY CYTRX CORPORATION TO HERCUL ex10-3_htiiiwarrant.htm EX-10.3 127129
5 PRESS RELEASE OF CYTRX CORPORATION ISSUED ON FEBRUARY 8, 2016. ex99-1_pressrelease02082016.htm EX-99.1 11807
6 image00003.jpg GRAPHIC 2574
7 image00004.jpg GRAPHIC 71749
  Complete submission text file 0000799698-16-000027.txt   832960
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
CYTRX CORP (Filer) CIK: 0000799698 (see all company filings)

IRS No.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15327 | Film No.: 161401083
SIC: 2836 Biological Products, (No Diagnostic Substances)